Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News archive
News Archive Navigation
News Archive Navigation Language
January 2020
-
Featured NewsNovartis 2019 Financial Results
Novartis announces the company’s fourth quarter and 2019 full year financial results.
-
Featured NewsNovartis at the World Economic Forum Annual Meeting Davos 2020
From January 21-24 2020, Novartis attended the World Economic Forum Annual Meeting in Davos, Switzerland.
-
Featured NewsNovartis at J.P Morgan 2020
From January 13-16 2020, Novartis attended the J.P Morgan Healthcare Conference in San Francisco.
December 2019
-
Featured NewsUncovering profound and under-reported effects on people living with sickle cell disease
Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.
-
Featured NewsNovartis R&D Day
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
-
Featured NewsAmazon Web Services (AWS) announces strategic collaboration with Novartis to accelerate digital transformation of its business operations
We’re collaborating with AWS to build an enterprise-wide data and analytics platform to transform the way medicines are manufactured and delivered.
-
Featured NewsBehind the research driving our data at medical conferences
Novartis data at 2019 ASH and SABCS underscore our evolving R&D approach in innovative platforms to reimagine medicine and help improve patient outcomes.
October 2019
-
Featured NewsNovartis Financial Results – Q3 2019
Novartis announced the company’s financial results for the third quarter of 2019.
-
Featured NewsPride @ Novartis 2019
As a company, we stand up for greater inclusion of LGBTI people because when each of us feels included, we all benefit.
-
Featured NewsNovartis and Microsoft announce collaboration to transform medicine with artificial intelligence
On Tuesday September 1, 2019 Novartis and Microsoft announced a multiyear alliance which will leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized. Novartis is also establishing an AI Innovation Lab to empower associates to use AI across our business.
Pagination
- ‹ Previous page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- › Next page